www.medical-devices.tech
21
'24
Written on Modified on
Terumo News
TERUMO BCT KICKS OFF U.S. LAUNCH OF REVEOS AUTOMATED BLOOD PROCESSING SYSTEM
Reveos is the first whole blood automation device available in the U.S. that processes whole blood into platelets and other components in a single centrifugation cycle.
www.terumo.com
Terumo Blood and Cell Technologies (Terumo BCT) has launched the Reveos™ Automated Blood Processing System in the United States to help blood centers meet blood and platelet supply needs while helping their staff work more efficiently. Carter BloodCare in Texas is getting ready to implement Reveos to manufacture platelets, red blood cells and plasma for transfusion.
Whole blood donations are common at community blood drives and blood centers. Those whole blood donations are usually separated, using a centrifuge, into their respective components — plasma, platelets and red blood cells. Healthcare providers use the different blood components for various patients based on need. In the U.S., the processing of whole blood required a series of more than 20 steps before Terumo BCT introduced Reveos.
Reveos is the first whole blood automation device available in the U.S. to process whole blood into three components — platelets, plasma and red blood cell concentrates — in a single centrifugation cycle. This streamlined process helps maximize the yield of whole blood donations, addressing the ongoing challenges of platelet shortages and the need for more efficient blood processing methods.
Blood Centers of America (BCA), with more than 50 independent blood centers nationally, is the first U.S. facility to adopt Reveos. BCA and its members have undertaken a great deal of work to ready its labs and train employees in this new way of working. Nonprofit Carter BloodCare, serving north, central and east Texas, is the first in BCA with Reveos.
Reveos offers several key benefits, including:
- Flexibility: By processing whole blood into three components in a single cycle, Reveos helps maximize the number of blood products produced from each donation.
- Costs: Because the system is automated, it significantly reduces operational costs for whole blood processing.
- Productivity: Reveos can reduce hands-on steps by up to 65% compared to manual processing methods.
The launch of the Reveos system in the U.S. comes at a critical time, as blood centers across the country continue to face challenges related to platelet shortages and staffing. By providing a more efficient and effective solution for whole blood processing, Reveos can help address these challenges and ensure a reliable supply of blood products for patients in need.
